Pages that link to "Q34292557"
Jump to navigation
Jump to search
The following pages link to Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin (Q34292557):
Displaying 50 items.
- Clinical Pharmacokinetics of Metformin (Q22241422) (← links)
- Pharmacogenetic studies update in type 2 diabetes mellitus (Q26739350) (← links)
- AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes (Q27300811) (← links)
- Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs) (Q28479037) (← links)
- The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice (Q28544698) (← links)
- A common 5'-UTR variant in MATE2-K is associated with poor response to metformin (Q30407583) (← links)
- Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk (Q31053398) (← links)
- Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake (Q33584577) (← links)
- Metformin pharmacogenomics: current status and future directions (Q33959731) (← links)
- An update on the pharmacogenomics of metformin: progress, problems and potential (Q34003050) (← links)
- Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin. (Q34224429) (← links)
- Taste of a pill: organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands (Q34245062) (← links)
- Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta (Q34616393) (← links)
- Metformin--mode of action and clinical implications for diabetes and cancer (Q34658712) (← links)
- Extraneuronal monoamine transporter mediates the permissive action of cortisol in the Guinea pig trachea: possible involvement of tracheal chondrocytes (Q35009290) (← links)
- Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone (Q35023736) (← links)
- A solute carrier family 22 member 3 variant rs3088442 G→A associated with coronary heart disease inhibits lipopolysaccharide-induced inflammatory response (Q35126576) (← links)
- Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3. (Q35164428) (← links)
- Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin (Q35745939) (← links)
- Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells (Q36016832) (← links)
- Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. (Q36095058) (← links)
- Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue. (Q36422420) (← links)
- Metformin pathways: pharmacokinetics and pharmacodynamics (Q36836472) (← links)
- The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. (Q36899802) (← links)
- Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects (Q36910592) (← links)
- Determinants of maternal triglycerides in women with gestational diabetes mellitus in the Metformin in Gestational Diabetes (MiG) study. (Q36942169) (← links)
- Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1. (Q37171418) (← links)
- Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs). (Q37315965) (← links)
- Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney (Q37366972) (← links)
- Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters (Q37369333) (← links)
- Pharmacogenetics and personalized treatment of type 2 diabetes (Q37508445) (← links)
- Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery (Q37824864) (← links)
- Role of organic cation transporters in drug-induced toxicity (Q37829434) (← links)
- Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery (Q38185970) (← links)
- A Comprehensive Review of Drug-Drug Interactions with Metformin (Q38460322) (← links)
- Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes. (Q38607553) (← links)
- Rosetta Broker for membrane protein structure prediction: concentrative nucleoside transporter 3 and corticotropin-releasing factor receptor 1 test cases (Q38642901) (← links)
- Metformin Accelerates Glycolytic Lactate Production in Cultured Primary Cerebellar Granule Neurons (Q38688703) (← links)
- Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin (Q38740932) (← links)
- Metformin prevents the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restricts hyperglycaemia-induced bacterial growth (Q38797366) (← links)
- Loops and layers of post-translational modifications of drug transporters (Q38833348) (← links)
- Prediction and validation of enzyme and transporter off-targets for metformin. (Q38838317) (← links)
- Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines (Q38973866) (← links)
- Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids (Q39098184) (← links)
- Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin (Q39302801) (← links)
- Association between the synonymous variant organic cation transporter 3 (OCT3)-1233G>A and the glycemic response following metformin therapy in patients with type 2 diabetes (Q40251170) (← links)
- Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin (Q40348845) (← links)
- Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates. (Q41152081) (← links)
- Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically (Q41891370) (← links)
- Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis. (Q41951897) (← links)